Navigation Links
Default options should be used to improve healthcare
Date:10/4/2007

PHILADELPHIA Anyone who has ever tried to set up an internet account or wants to make a purchase on a companys website, has experienced the default option, an event or condition that will be set in place if no alternative is actively chosen.

In an opinion article in the September 28 issue of the New England Journal of Medicine, lead author Scott D. Halpern, M.D., instructor of Epidemiology in the Department of Biostatistics and Epidemiology at the University of Pennsylvania School of Medicine, and colleagues, argue that these concepts applied by marketers should also be used by the medical community to benefit patients. Additional authors are Peter A. Ubel, M.D., and David A. Asch, M.D., M.B.A. When designed properly, the authors write, default options can achieve three goals:

  • Improve care for individual patients

  • Improve health care in hospitals and allied settings

  • Promote cost-containment and other social agendas.

The authors cite examples of potential default options that are easily implemented and would result in an overall benefit. A policy to remove urinary catheters in hospitalized patients after 72 hours unless physicians or nurses document a reason for maintaining them, could reduce the hospital-borne infections.

Organ donations are another example. The change from opt-in to opt-out policies has increased donation rates in many European countries, the authors note.

According to Halpern, who is also a fellow in the division of Pulmonary, Allergy and Critical Care Medicine in the University of Pennsylvania Health System, the current system allows defaults to be set haphazardly. Instead, physicians and policymakers have a great opportunity to set defaults in ways that help to improve the health of individual patients as well as our entire health-care system.

Sometimes default options should not be used, however, and the authors note that these circumstances also need to be identified. The computerized patient order system, for example, which is used in most U.S. hospitals, should encourage physicians to actively select a specific dose for each medication ordered rather than defaulting to the lowest or the most popular dose. The absence of a default option forces physicians to consider the most appropriate dose for each patient and it should minimize the risks of overdosing or under dosing that these systems may generate.

Not only can health-care outcomes benefit from a thoughtful default strategy, the authors write, they can accrue cost-savings as well. The policy whereby drug prescriptions default to generic medications unless physicians check a brand necessary box promotes the social goal of decreasing health-care expenditures.

Establish clear-cut options when it is a given that some action should be taken. For example, patients who have trouble choosing between the recommended screenings for colon cancercolonoscopy and sigmoidoscopy plus fecal occult-blood testingmay avoid either test. In such cases, a default option to either screening method should ensure that it is done.

In conclusion, the authors state that our current approach to default options in health care has itself been too passive, and opportunities exist throughout the health care system to use these options more strategically.

Enacting policy changes by manipulating default options carries no more risk than ignoring such options that were previously set passively, and it offers far greater opportunities for benefit.


'/>"/>

Contact: Nan Myers
nan.myers@uphs.upenn.edu
University of Pennsylvania School of Medicine
Source:Eurekalert

Related medicine news :

1. Brain’s "Default Mode" Awry in Schizophreni
2. Better Treatment Options For Osteoporosis
3. The Options For Relieving Chest Pain In the Elderly Questioned
4. Treatment Options For Retinitis Pigmentosa Questioned
5. More Treatment Options For Malaria
6. Unbiased Treatment Options Required For Breast Cancer Patients
7. Women Poorly Informed About Contraceptive Options: Doctors Blamed
8. Misconception on Treatment Options among Prostate Cancer Patients
9. Improving Treatment Options for Multiple Sclerosis
10. Survival rates improve with better treatment options for medulloblastoma
11. Options Improving for Patients With Acromegaly and Gigantism
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/22/2017)... ... September 22, 2017 , ... ... tick-borne diseases through research, education and awareness, today announced the appointment of Timothy ... and microbiologist, Dr. Sellati has more than 20 years of research experience with ...
(Date:9/21/2017)... ... September 21, 2017 , ... ... — 1:30 p.m. – 3:00 p.m. ET, http://www.fdanews.com/processcapabilityindices      ... things wrong, run afoul of The Quality System Regulation (§820.250), and Devicemakers find ...
(Date:9/21/2017)... ... September 21, 2017 , ... Promotional ... http://www.fdanews.com/products/54818-promotional-communication      , In the competitive world of drug and device marketing ... in compliance with FDA rules. , The FDA has issued two draft guidances ...
(Date:9/21/2017)... ... September 21, 2017 , ... Bill Howe Plumbing’s mission is to create ... back to the community. For over 37 years, they have operated with their mission ... plumbing in San Diego. They were chosen as the Best San Diego plumber ...
(Date:9/21/2017)... Southborough, Mass. (PRWEB) , ... September 21, 2017 , ... ... for children with autism, announced today the election of Yie-Hsin Hung to the Board ... Yie-Hsin Hung join our Board of Directors. Ms. Hung is an invaluable addition to ...
Breaking Medicine News(10 mins):
(Date:9/7/2017)... BOTHELL, Wash. , Sept. 7, 2017   BioLife ... developer, manufacturer and marketer of proprietary clinical grade cell and ... media ("BioLife"), announces that Mike Rice , President and ... Rodman & Renshaw 19 th ... 3:25 p.m. Eastern time (12:25 p.m. Pacific time). The conference ...
(Date:9/6/2017)... 2017 Eli Lilly and Company (NYSE: ... data for galcanezumab and lasmiditan, two investigational treatments for ... Society (IHC) taking place Sept. 7-10 in ... new, long-term data from an open-label study evaluating the ... mg and 240 mg) for the prevention of migraine. ...
(Date:9/5/2017)... Oramed Pharmaceuticals Inc. (NASDAQ: ORMP ) (TASE: ... on the development of oral drug delivery systems, announced ... the U.S. Food and Drug Administration (FDA) regarding ORMD-0801, ... At the meeting, the FDA gave ... ORMD-0801, would be a Biologics License Application (BLA).  Such ...
Breaking Medicine Technology: